Treating Multiple Myeloma with Bisphosphonates
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. Noopur Raje discusses treating myeloma with bisphosphonates with Andrew Schorr from Patient Power. Dr. Noopur Raje advocates the use of bisphosphonates in treating symptomatic myeloma, and explains how they work on the accessory cells which surround myeloma cells. She discusses the side effects related to the toxicities of bisphosphonates such as osteonecrosis of the jaw (ONJ). Current guidelines suggest bisphosphonates treatment for up to two years. Dr. Raje will be releasing data from a recent study supporting reducing the frequency of bisphosphonates treatments to every three months.
Stem Cell Transplant for Multiple Myeloma
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger of Seattle Cancer Care Alliance, discusses the treatment of myeloma with stem cell transplant. He describes an autologous transplant, where high doses of drugs such as melphalan to eradicate the myeloma, and outlines the side effects. Dr. Bensinger tells about clinical trials which are trying to determine if transplants as part of the initial therapy or later in the course of disease treatment is more effective.
Limiting Myeloma Treatment Side Effects
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Noopur Raje discuss ways to limit the side effects of treatment for myeloma with Andrew Schorr from Patient Power. Dr. Raje states that the goal is not just to live longer, but to live longer well. Because every patient experiences different side effects from the treatment of the disease, Dr. Raje says the key is communication with your medical team, including nurses. Listen for more tips on managing side effects of myeloma treatment.